411 related articles for article (PubMed ID: 31999714)
21. Treatment and Low-Density Lipoprotein Cholesterol Management in Patients Diagnosed With Clinical Atherosclerotic Cardiovascular Disease in Alberta.
Chen G; Farris MS; Cowling T; Colgan SM; Xiang P; Pericleous L; Rogoza RM; Tai MH; Anderson T
Can J Cardiol; 2019 Jul; 35(7):884-891. PubMed ID: 31292087
[TBL] [Abstract][Full Text] [Related]
22. Low-density lipoprotein cholesterol goal attainment rates in high-risk patients with cardiovascular diseases and diabetes mellitus in Korea: a retrospective cohort study.
Yang YS; Yang BR; Kim MS; Hwang Y; Choi SH
Lipids Health Dis; 2020 Jan; 19(1):5. PubMed ID: 31926562
[TBL] [Abstract][Full Text] [Related]
23. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
[TBL] [Abstract][Full Text] [Related]
24. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
25. Current Status of Low-Density Lipoprotein Cholesterol Target Achievement in Patients with Type 2 Diabetes Mellitus in Korea Compared with Recent Guidelines.
Yun SJ; Jeong IK; Cha JH; Lee J; Cho HC; Choi SH; Chun S; Jeon HJ; Kang HC; Kim SS; Ko SH; Koh G; Kwon SK; Lee JH; Moon MK; Noh J; Park CY; Kim S
Diabetes Metab J; 2021 May; 46(3):464-475. PubMed ID: 35235742
[TBL] [Abstract][Full Text] [Related]
26. Risk of cardiovascular events in patients at optimal values for combined lipid parameters.
Stanek EJ; Sarawate C; Willey VJ; Charland SL; Cziraky MJ
Curr Med Res Opin; 2007 Mar; 23(3):553-63. PubMed ID: 17357251
[TBL] [Abstract][Full Text] [Related]
27. Achievement rates of Japan Atherosclerosis Society Guidelines 2007 LDL-cholesterol goals with rosuvastatin or atorvastatin in patients who had not achieved their goal with atorvastatin.
Shioji K; Izuhara M; Mitsuoka H; Uegaito T; Matsuda M;
Cardiovasc Ther; 2014 Jun; 32(3):97-104. PubMed ID: 24456217
[TBL] [Abstract][Full Text] [Related]
28. Compliance With Dyslipidemia Guidelines in Daily Practice: How Effective Is Cardiovascular Risk Prevention?
Güntekin Ü; Gümrükçüoğlu HA; Yaman M; Öztürk F; Akyol A; Gümrükçüoğlu FN; Okudan YE; Tosun V; Kandemir YB
Clin Ther; 2018 Dec; 40(12):2031-2040. PubMed ID: 30392816
[TBL] [Abstract][Full Text] [Related]
29. DemographIc Assessment and EValuation of DEgree of Lipid Control in High Risk Indian DySlipidemia PatiEnts (DIVERSE Study).
Malhotra N; Keshan MK; Agarwal A; Kumar RA; Trailokya A; Dalvi K; Talele S
J Assoc Physicians India; 2016 Apr; 64(4):38-46. PubMed ID: 27734640
[TBL] [Abstract][Full Text] [Related]
30. Dyslipidemia control in indigent patients receiving medication assistance compared with insured patients.
Marrs JC; Saseen JJ
Pharmacotherapy; 2008 May; 28(5):562-9. PubMed ID: 18447654
[TBL] [Abstract][Full Text] [Related]
31. Blood pressure and lipid target adherence in Korean patients receiving angiotensin II receptor blockers/statin regimens.
Kim HJ; Kim E; Min KB; Min JY
Curr Med Res Opin; 2017 Feb; 33(2):385-390. PubMed ID: 27819152
[TBL] [Abstract][Full Text] [Related]
32. Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patients.
Munkhaugen J; Sverre E; Otterstad JE; Peersen K; Gjertsen E; Perk J; Gullestad L; Moum T; Dammen T; Husebye E
Eur J Prev Cardiol; 2017 Jun; 24(9):981-989. PubMed ID: 28196429
[TBL] [Abstract][Full Text] [Related]
33. Achieving recommended low density lipoprotein cholesterol goals and the factors associated with target achievement of hypercholesterolemia patients with rosuvastatin in primary care.
Lee JA; Sunwoo S; Kim YS; Oh HJ; Kang HC; Park KC; Sin DH; Lee SY; Yang YJ; Yu BY; Kim CM
Curr Med Res Opin; 2013 Jul; 29(7):751-60. PubMed ID: 23647398
[TBL] [Abstract][Full Text] [Related]
34. Factors associated with therapeutic goal attainment in patients with concomitant hypertension and dyslipidemia.
Chopra I; Kamal KM
Hosp Pract (1995); 2014 Apr; 42(2):77-88. PubMed ID: 24769787
[TBL] [Abstract][Full Text] [Related]
35. Attainment of low-density lipoprotein cholesterol goal after endovascular treatment is associated with reduced cardiovascular events in patients with peripheral arterial disease.
Lee JH; Ko YG; Shin DH; Kim JS; Kim BK; Choi D; Hong MK; Jang Y
J Vasc Surg; 2016 Mar; 63(3):756-63. PubMed ID: 26603545
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of LDL goal achievement in statin consumption, south east of Iran.
Aghasizadeh M; Bizhaem SK; Baniasadi M; Khazdair MR; Kazemi T
Sci Rep; 2021 May; 11(1):10786. PubMed ID: 34031484
[TBL] [Abstract][Full Text] [Related]
37. Achievement of low density lipoprotein (LDL) cholesterol targets in primary and secondary prevention: Analysis of a large real practice database in Italy.
Presta V; Figliuzzi I; Miceli F; Coluccia R; Fogacci F; Cicero AFG; Ferrucci A; Borghi C; Volpe M; Tocci G;
Atherosclerosis; 2019 Jun; 285():40-48. PubMed ID: 31003091
[TBL] [Abstract][Full Text] [Related]
38. Long-term achievement of the therapeutic objectives of lipid-lowering agents in primary prevention patients and cardiovascular outcomes: an observational study.
Van Ganse E; Souchet T; Laforest L; Moulin P; Bertrand M; Le Jeunne P; Chretin S; Yin D; Alemao E; de Pouvourville G
Atherosclerosis; 2006 Mar; 185(1):58-64. PubMed ID: 16038912
[TBL] [Abstract][Full Text] [Related]
39. Prospective analysis of LDL-C goal achievement and self-reported medication adherence among statin users in primary care.
Bermingham M; Hayden J; Dawkins I; Miwa S; Gibson D; McDonald K; Ledwidge M
Clin Ther; 2011 Sep; 33(9):1180-9. PubMed ID: 21840055
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
